description

Sanofi and Regeneron Pharmaceuticals said they will slash the U.S. list price of their potent but expensive cholesterol fighter Praluent by 60 percent. Reuters reports the new list price for Praluent will be $5,850 a year, matching the price Amgen set when it lowered the list of its competing drug, Repatha, in October. Sanofi and Regeneron said they expect the lower-priced Praluent to be available for pharmacies to order in early March.

general info

  • Uploaded    02/11/2019
  • News & Politics
  • Normally Affable Warren Buffet Sends Shareholders A Rather Grumpy Annu...
  • Nigerian Candidates Remain Confident In Close, Oft-Delayed Election
  • YouTube Takes Steps To Combat Inappropriate Content
  • R. Kelly's Has Bail Set At $1 Million, Forbidden From Communicating Wi...
  • Patriots Owner Charged in Soliciting Prostitution
  • Wales Beats England In Rugby
  • Frantic, Hungry Venezuelans Clash With Soldiers As Maduro Blocks Human...
  • Venezuela Protests Flare, Soldiers Defect Ahead of Border Aid Operatio...
  • Singer R. Kelly Faces New Charges